Raised serum levels of IgM-rheumatoid factor and anti-F(ab')2 autoantibodies in patients with active inflammatory bowel disease
- PMID: 3014152
Raised serum levels of IgM-rheumatoid factor and anti-F(ab')2 autoantibodies in patients with active inflammatory bowel disease
Abstract
The serum levels of IgM-Rheumatoid Factor and of anti-F(ab')2 autoantibodies were investigated in patients with inflammatory Bowel Disease (IBD) by sensitive radioimmunoassays. Serum levels of the 2 autoantibodies were significantly increased in active IBD. In patients with Crohn's Disease raised titers of the 2 antibodies appeared to be also related to colonic involvement. There was, in Crohn's Disease, a significant association between concordantly positive results with the 2 assays and the occurrence of systemic complications. Immunocomplexes detected by the C1q-SP method were higher in sera of Crohn's Disease patients with raised IgM-RF than in the others. Data from the present investigation indicate that in active IBD and particularly in Crohn's Disease autoantibodies directed against different parts of the immunoglobulin molecule may be produced. These findings add support to the concept that an in vivo polyclonal B-cell activation may occur in these patients.
Similar articles
-
Detection of rheumatoid factors of different isotypes and of circulating immune complexes in patients with inflammatory bowel disease.Boll Ist Sieroter Milan. 1990 Jun;69(2):413-21. Boll Ist Sieroter Milan. 1990. PMID: 2152301
-
Measles IgM immunoreactivity in patients with inflammatory bowel disease.Ital J Gastroenterol Hepatol. 1998 Aug;30(4):378-82. Ital J Gastroenterol Hepatol. 1998. PMID: 9789132
-
Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?Eur J Gastroenterol Hepatol. 1995 Sep;7(9):859-64. Eur J Gastroenterol Hepatol. 1995. PMID: 8574718
-
C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.Gut. 2008 Nov;57(11):1518-23. doi: 10.1136/gut.2007.146357. Epub 2008 Jun 19. Gut. 2008. PMID: 18566104
-
Immunoglobulin M memory B cell decrease in inflammatory bowel disease.Eur Rev Med Pharmacol Sci. 2004 Sep-Oct;8(5):199-203. Eur Rev Med Pharmacol Sci. 2004. PMID: 15638230
Cited by
-
Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn's disease but not ulcerative colitis patients.Clin Exp Immunol. 1993 Apr;92(1):152-7. doi: 10.1111/j.1365-2249.1993.tb05962.x. Clin Exp Immunol. 1993. PMID: 8467559 Free PMC article.
-
The specificity of antiglobulin autoantibodies in patients with primary Sjögren's syndrome.Clin Rheumatol. 1990 Dec;9(4):501-8. doi: 10.1007/BF02030512. Clin Rheumatol. 1990. PMID: 2088647
-
A limiting-dilution analysis of activated circulating B cells in Crohn's disease.J Clin Immunol. 1990 Mar;10(2):128-34. doi: 10.1007/BF00918195. J Clin Immunol. 1990. PMID: 2187016
-
Expression of CD45RO on circulating CD19+ B-cells in Crohn's disease.Gut. 1993 Dec;34(12):1698-704. doi: 10.1136/gut.34.12.1698. Gut. 1993. PMID: 7506695 Free PMC article.
-
Absence of circulating interferon in patients with inflammatory bowel disease. Suggestion against an autoimmune etiology.Clin Exp Immunol. 1992 Oct;90(1):85-7. doi: 10.1111/j.1365-2249.1992.tb05836.x. Clin Exp Immunol. 1992. PMID: 1382905 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical